{"id":"NCT03395808","sponsor":"Avenue Therapeutics, Inc.","briefTitle":"Evaluate Safety of Tramadol in the Management of Postoperative Pain Following Surgery","officialTitle":"A Phase 3, Multicenter, Single-Arm, Open-Label Study to Evaluate the Safety of Tramadol Infusion (AVE-901) in the Management of Post-Operative Pain Following Surgery","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-12-22","primaryCompletion":"2019-04-25","completion":"2019-05-06","firstPosted":"2018-01-10","resultsPosted":"2021-03-09","lastUpdate":"2021-03-09"},"enrollment":251,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"OTHER"},"conditions":["Pain Management"],"interventions":[{"type":"DRUG","name":"Tramadol","otherNames":[]}],"arms":[{"label":"AVE-901 50mg","type":"OTHER"}],"summary":"The study evaluates the safety of IV tramadol managing post-operative pain following surgery.","primaryOutcome":{"measure":"Adverse Events","timeFrame":"Up to 21 days","effectByArm":[{"arm":"IV Tramadol 50 mg","deltaMin":251,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":15},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":251},"commonTop":["Nausea","Vomitting","Hypoxia","Blood creatine phosphokinase increased","Constipation"]}}